http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35517862

Outgoing Links

Predicate Object
contentType Journal Article|Comment
endingPage 514
issn 1072-7515
issueIdentifier 3
pageRange 512-514
publicationName Journal of the American College of Surgeons
startingPage 512
bibliographicCitation Premji AM, Donahue TR. Invited Commentary: Adjuvant Chemotherapy Is Beneficial in Stage III Ampullary Adenocarcinoma. J Am Coll Surg. 2023 Sep 01;237(3):512–4. doi: 10.1097/xcs.0000000000000766. PMID: 37260119.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4799f519b256d75e9f82f54ea346cca9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d749c98f507787c66de86970802dd2bf
date 2023-06-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/37260119
https://doi.org/10.1097/xcs.0000000000000766
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8488
https://portal.issn.org/resource/ISSN/1072-7515
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Invited Commentary: Adjuvant Chemotherapy Is Beneficial in Stage III Ampullary Adenocarcinoma
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D003138Q000188
http://id.nlm.nih.gov/mesh/D003138Q000601
http://id.nlm.nih.gov/mesh/D014670Q000601
http://id.nlm.nih.gov/mesh/D000230Q000188
http://id.nlm.nih.gov/mesh/D000230Q000601
hasSubjectTerm http://id.nlm.nih.gov/mesh/D009367
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D017024
http://id.nlm.nih.gov/mesh/D006801

Showing number of triples: 1 to 28 of 28.